Swiss National Bank - SAGENT PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Swiss National Bank ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$589,000
+49.9%
39,300
+17.0%
0.00%0.0%
Q1 2016$393,000
-7.1%
33,600
+26.3%
0.00%0.0%
Q4 2015$423,000
+3.7%
26,6000.0%0.00%0.0%
Q3 2015$408,000
-26.1%
26,600
+17.2%
0.00%0.0%
Q2 2015$552,000
+16.5%
22,700
+11.3%
0.00%0.0%
Q1 2015$474,000
-7.4%
20,4000.0%0.00%
-50.0%
Q4 2014$512,000
-19.2%
20,4000.0%0.00%0.0%
Q3 2014$634,000
+20.1%
20,4000.0%0.00%0.0%
Q2 2014$528,000
+55.8%
20,400
+40.7%
0.00%
+100.0%
Q1 2014$339,000
+15.3%
14,500
+25.0%
0.00%0.0%
Q4 2013$294,000
+24.1%
11,6000.0%0.00%0.0%
Q3 2013$237,000
+13.9%
11,600
+17.2%
0.00%0.0%
Q2 2013$208,0009,9000.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 462,824$7,364,0008.63%
HealthCor Management, L.P. 1,750,000$27,843,0001.69%
ACUTA CAPITAL PARTNERS, LLC 144,667$2,302,0001.10%
THB ASSET MANAGEMENT 615,546$9,793,0001.05%
Penn Capital Management Company, LLC 1,399,205$22,261,0000.98%
Tamarack Advisers, LP 450,000$7,160,0000.94%
Piermont Capital Management Inc. 139,020$2,212,0000.70%
JW Asset Management, LLC 101,630$1,617,0000.60%
SECTORAL ASSET MANAGEMENT INC 810,362$12,893,0000.55%
Glacier Peak Capital LLC 50,000$796,0000.51%
View complete list of SAGENT PHARMACEUTICALS INC shareholders